An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials

BACKGROUND: Adequate organ function and good performance status (PS) are common eligibility criteria for phase I trials. As inflammation is pathogenic and prognostic in cancer we investigated the prognostic performance of inflammation-based indices including the neutrophil (NLR) and platelet to lymp...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinato, David J., Stavraka, Chara, Flynn, Michael J., Forster, Martin D., O'Cathail, Séan M., Seckl, Michael J., Kristeleit, Rebecca S., Olmos, David, Turnbull, Samantha J., Blagden, Sarah P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883636/
https://www.ncbi.nlm.nih.gov/pubmed/24409281
http://dx.doi.org/10.1371/journal.pone.0083279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883636/
https://www.ncbi.nlm.nih.gov/pubmed/24409281
http://dx.doi.org/10.1371/journal.pone.0083279

Ejemplares similares